Concepedia

Author

Daria J. Hazuda

United States Military AcademyORCID

Also Known As

Archin, Nancie M., D Hazuda, D J Hazuda, D. Hazuda, D. J. HAZUDA, D. J. Hazuda, D.J. Hazuda, DARIA J. HAZUDA, Daria Hazuda, Daria J Hazuda

328

Publications

23.7K

Citations

76

H-Index

155

Concepts

All Affiliations

United States Military AcademyMerck & Co., Inc., Rahway, NJ, USA (United States)University of North Carolina at Chapel Hill
DJ

About

Daria J. Hazuda is an author at United States Military Academy specializing in medicine, hiv, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

56

129

13.2K

2

Natural Sciences

32

47

5.5K

3

Engineering

6

6

498

4

Health Sciences

3

3

140

5

Public Health

1

1

14

Daria J. Hazuda

×

191

Publications

20K

Citations

72

H-Index

YearCitations

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Nancie M. Archin, Abigail Liberty, Angela D. M. Kashuba,

Nature

2012

1.1K

Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

Daria J. Hazuda, Peter J. Felock, Marc Witmer,

Science

2000

1.1K

Genome-Scale RNAi Screen for Host Factors Required for HIV Replication

Honglin Zhou, Min Xu, Qian Huang,

Cell Host & Microbe

2008

773

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar,

New England Journal of Medicine

2008

683

Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

Vincenzo Summa, Alessia Petrocchi, Fabio Bonelli,

Journal of Medicinal Chemistry

2008

624

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

Helena Mancebo, Gary Lee, John A. Flygare,

Genes & Development

1997

536

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

David A. Cooper, Roy T. Steigbigel, José M. Gatell,

New England Journal of Medicine

2008

505

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

Julian Elliott, Fiona Wightman, Ajantha Solomon,

PLoS Pathogens

2014

504

Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes

Jay A. Grobler, Kara A. Stillmock, Binghua Hu,

Proceedings of the National Academy of Sciences

2002

395

Xenopus transcription factor A requires zinc for binding to the 5 S RNA gene.

Jay S. Hanas, Daria J. Hazuda, Daniel Bogenhagen,

Journal of Biological Chemistry

1983

357

Page 1